Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
BackgroundDeep brain stimulation (DBS) of the subthalamic nucleus (STN) is an established therapy for advanced Parkinson's disease (PD), primarily targeting motor complications refractory to pharmacological treatment. However, its long-term impact on functional autonomy and quality of life (QoL) remains debated.ObjectiveThis systematic review with meta-analysis aimed to evaluate the effects of STN-DBS on autonomy and QoL in people with PD.MethodsFollowing PRISMA guidelines, a systematic search of PubMed, Scopus, Embase and Web of Science was conducted to identify studies including adults with PD treated with STN-DBS and reporting measures of autonomy and/or quality of life.ResultsThirty-two studies met inclusion criteria. Meta-analyses showed effect estimates favoring DBS at 6 months (SMD = 0.83[0.38;1.29]) and at 1 year (SMD = 0.49[-0.02;0.99]) for autonomy. Similar trends were observed for QoL, with SMD = 0.60[0.49;0.71] at 6 months and SMD = 0.48[0.0;0.96] at 1 year.At 2 years, small but significant pooled effects persisted, for both autonomy SMD = 0.40[0.13;0.67] and QoL SMD = 0.25[-0.04;0.53]. However, at 5 years, pooled effects were no longer statistically significant for either autonomy SMD = 0.37[-0.55;1.29] or QoL SMD = -0.01[-0.25;0.22], indicating a progressive attenuation of benefit over time.ConclusionsSTN-DBS provides robust short- and mid-term benefits in functional autonomy and QoL in PD. Long-term outcomes are variable and influenced by disease progression and non-motor symptoms. Standardized outcome reporting, larger multicenter trials, and integration of rehabilitative and psychosocial interventions are needed to optimize benefits.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.